Sign Up to like & get recommendations! 1
Published in 2022 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3565
Abstract: Several reports indicate that diabetes determines an increased mortality risk in patients with coronavirus disease 19 (COVID‐19) and a good glycaemic control appears to be associated with more favourable outcomes. Evidence also supports that COVID‐19… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Cellular Physiology"
DOI: 10.1002/jcp.30807
Abstract: Cardiovascular disease (CVD) is the leading cause of death in various complications of type 2 diabetes mellitus (T2DM). Rivaroxaban (Xarelto; Bayer), an oral direct factor Xa (FXa) inhibitor, prevents the activation of the coagulation cascade… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Liver Transplantation"
DOI: 10.1002/lt.26572
Abstract: To the editor, Liver transplantation (LT) recipients have an increased risk of developing cardiovascular disease (CVD), but the physiological mechanisms driving this risk are not yet fully understood. A decline in renal function after transplant… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Pulmonary Circulation"
DOI: 10.1002/pul2.70144
Abstract: ABSTRACT Chronic obstructive pulmonary disease (COPD) is frequently accompanied by abnormalities of the pulmonary vasculature. This vasculopathy spans the spectrum from mild vascular dysfunction to pulmonary hypertension, which on rare occasions can be severe. Given… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Methods in molecular biology"
DOI: 10.1007/978-1-4939-6786-5_30
Abstract: Vascular inflammation in cardiovascular diseases is recognized to be linked with immune cell activation. Recruitment of immune cells into the vessel wall is an early step in angiotensin II-induced vascular dysfunction and arterial hypertension. Exploring… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Life Sciences"
DOI: 10.1016/j.lfs.2018.11.030
Abstract: Aims: Inflammation is involved in diabetes‐related vascular dysfunction. Estrogen receptor ESR2/ER&bgr; induces the expression of inducible nitric oxide (NO) synthase (iNOS) and inflammation. The present study investigated the effect of alloxan‐induced type 1 diabetes on… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Neurobiology of Disease"
DOI: 10.1016/j.nbd.2018.07.009
Abstract: BACKGROUND Hypertension-induced microvascular brain injury is a major vascular contributor to cognitive impairment and dementia. We hypothesized that chronic hypoxia promotes the hyperphosphorylation of tau and cell death in an accelerated spontaneously hypertensive stroke prone… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2018.01.007
Abstract: BACKGROUND Cardiovascular diseases play a major role in morbidity and mortality in the earlier stages of COPD. We hypothesized that systemic vascular dysfunction would be present even in patients who are currently considered at "low-risk"… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Toxicology"
DOI: 10.1016/j.tox.2019.05.016
Abstract: BACKGROUND/AIMS Patients with doxorubicin (Dox) treatment have a high risk of developing vascular toxicity with an unknown mechanism. l-arginine is a substrate for nitric oxide (NO). The decreased level of arginine-NO metabolite in Dox-treated cancer… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Genomics"
DOI: 10.1016/j.ygeno.2020.09.055
Abstract: Hyperlipidemia-induced retinal vascular dysfunction is a complex pathological process. circRNAs are important regulators of biological processes and disease progression. However, the expression pattern of circRNAs in hyperlipidemia-induced retinal vascular dysfunction remains unclear. Herein, we used… read more here.